Haemorrhagic Fever

Haemorrhagic fever refers to a group of severe, life-threatening illnesses characterized by fever, bleeding tendencies, and organ failure. Several viruses are associated with haemorrhagic fevers, each presenting distinct clinical features and geographic distributions. Notable viral causes include the Ebola virus, Marburg virus, Lassa virus, Crimean-Congo hemorrhagic fever virus, and Yellow fever virus. Ebola virus and Marburg virus, both members of the Filoviridae family, can cause Ebola and Marburg haemorrhagic fevers, respectively. These viruses are known for their high fatality rates and are transmitted to humans through direct contact with infected animals or individuals. The diseases often progress rapidly, leading to severe bleeding, multi-organ failure, and death. Lassa fever is caused by the Lassa virus, a member of the Arenaviridae family. Endemic in West Africa, Lassa fever is transmitted through contact with infected rodents or their excreta. While the majority of Lassa fever cases are mild, severe cases can result in hemorrhagic manifestations and organ failure. Crimean-Congo hemorrhagic fever (CCHF) is caused by the CCHF virus, a tick-borne virus belonging to the Bunyaviridae family. CCHF can cause severe outbreaks, with initial flu-like symptoms progressing to hemorrhage, thrombocytopenia, and organ failure. The virus is transmitted to humans through tick bites or contact with infected animal blood. Yellow fever, caused by the Yellow fever virus (Flaviviridae family), is characterized by fever, jaundice, and bleeding. Transmitted through mosquito bites, Yellow fever primarily affects tropical regions of Africa and South America. Vaccination is a key preventive measure against Yellow fever. Management of haemorrhagic fevers involves supportive care, as no specific antiviral therapies are widely available. Preventive measures include strict infection control practices, vector control for mosquito-borne viruses, and, where applicable, vaccination.